832
Views
26
CrossRef citations to date
0
Altmetric
Review

Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

, &
Pages 1-19 | Published online: 07 Mar 2008

References

  • Abu-DahabRSchäferUFLehrC-MLectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesionEur J Pharm Sci200114374611457648
  • AdjeiLAGuptaPKLenfantCInhalation delivery of therapeutic peptides and proteinsLung biology in health and disease1997New YorkMarcel Dekker, Inc1913
  • ArmstrongDJElliottPNCFordJLPoly – (D,L – lactic acid) microspheres incorporating histological dyes for intra-pulmonary histopathological investigationsJ Pharm Pharmacol199648258628737050
  • ArppeJVidgrenMWaldrepJCPulmonary pharmacokinetics of cyclosporin A liposomesInt J Pharm199816120514
  • BenameurHLatourNSchandeneLLiposome-incorporated dexamethasone palmitate inhibits in-vitro lymphocyte response to mitogenJ Pharm Pharmacol199547812178583348
  • BennettJVde CastroJFValdespino-GomezJLAerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccine: randomized trials in Mexican school childrenBulletin of the World Health Organisation20028080612
  • BeyerJSchwartzSBarzenGUse of amphotericin B aerosols for the prevention of pulmonary AspergillosisInfection19942214388070928
  • BotALTararaTESmithDJNovel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tractPharm Res2000172758310801215
  • BrooksADTongWBenedettiFInhaled aerosolization of all-trans-retinoic acid for targeted pulmonary deliveryCancer Chemother Pharmacol2000463131811052629
  • BrownDMWilsonMRMacNeeWSize-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafinesToxicologly Applied Pharmacol20011751919
  • BrownRAJrSchankerLSAbsorption of aerosolized drugs from the rat lungDrug Metab Disp19831135560
  • ButzNPortéCCourrierHReverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane proppellantsInt J Pharm20022382576911996829
  • ChettyDJChienYWNovel methods of insulin delivery: an updateCrit Rev Ther Drug Carrier19981562970
  • ChoiceEMasinDBallyMBLiposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistributionTransplantation1995601006117491673
  • ColthorpePFarrSJSmithIJThe influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbitsPharm Res19951235697617520
  • ColthorpePSFarrSJTaylorGThe pharmacokinetics of pulmonary delivered insulin: a comparison of IT and aerosol administration to the rabbitPharm Res1992976481409359
  • ConnellyJCPetersonBTClearance of Tc-labeled albumin from lungs in anesthetized guinea pigsExp Lung Res199319237558467764
  • CourrierHMButzNVandammeThFPulmonary drug delivery systems: recent developments and prospectsCrit Rev Ther Drug Carrier Syst2002194259812661699
  • CourrierHMKrafftMPButzNEvaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphateBiomaterials2003246899612437963
  • CourrierHMPonsFLessingerJMIn vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary routeInt J Pharm20042821314015336388
  • CourrierHMVandammeTFKrafftMPReverse water-influorocarbon emulsions and microemulsions obtained with a fluorinated surfactantColloids and Surface A: Physicochemical and Engineering Aspects20042441418
  • CourrierHMVandammeTFKrafftMPMixed monolayers made from dipalmitoylphosphatidylcholine and a fluorinated amphiphileColloids and Surface A: Physicochemical and Engineering Aspects20032153341
  • CouvreurPVauthierCNanotechnology: intelligent design to treat complex diseasePharm Res20062314175016779701
  • CullisPRMayerLDBallyMBGenerating and loading of liposomal systems for drug delivery systemsAdv Drug Deliv Rev1989326782
  • DarwisYKellawayIWNebulization of rehydrated freeze dried beclomethasone dipropionate liposomesInt J Pharm20012151132111250097
  • DavidsenJVermehrenCFrokjaerSDrug delivery by phospholipase A2 degradable liposomesInt J Pharm200121467911282239
  • DellamaryLATararaTESmithDJHollow porous particles in metered dose inhalersPharm Res2000171687410751031
  • DemaeyerPAkodadEMGravetEDisposition of liposomal gentamicin following intrabronchial administration in rabbitsJ Microencapsul19931077888445509
  • DickinsonPAHowellsSWKellawayIWNovel nanoparticles for pulmonary drug administrationJ Drug Targeting20019295302
  • DuchêneDPonchelGWouessidjeweDCyclodextrins in targeting. Application to nanoparticlesAdv Drug Del Rev1999362940
  • DuchêneDWouessidjeweDPonchelGCyclodextrins and carrier systemsJ Control Rel1999622638
  • EdwardsDAHanesJCaponettiGLarge porous particles for pulmonary drug deliveryScience19972761868719188534
  • El-BaseirMMKellawayIWPoly(lactic acid) microspheres for pulmonary drug delivery: release kinetics and aerosolization studiesInt J Pharm199817513546
  • El-BaseirMMPhippsMAKellawayIWPreparation and subsequent degradation of poly(L-lactic acid) microspheres suitable for aerosolization: a physicochemical studyInt J Pharm199715114553
  • EvansRMFarrSJAerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulationsUS005230884A1993UK
  • EylesJEWilliamsonEDSpiersIDProtection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis fiand V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacyVaccine20001832667110869771
  • FahrAHolzMFrickerGLiposomal formulations of cyclosporin A: Influence of lipid type and dose on pharmacokineticsPharm Res1995121189987494833
  • FarrSJKellawayIWParry-JonesDR99mTechnetium as a markers of liposomal deposition and clearance in the human lungInt J Pharm19852630316
  • FengS-SChienSChemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChem Engin Sci2003584087114
  • FengSSMuLChenBHPolymeric nanospheres fabricated with naturel emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)Mat Sci Eng2002C 208592
  • FrenchDLEdwardsDANivenRWThe influence of formulation on emission, deaggregation and deposition of dry powders for inhalationJ Aerosol Sci19962776983
  • GaberNNDarwisYPehK-KCharacterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionateJ Nanosci Nanotechnol20066309510117048523
  • GilbertBESixHRWilsonSZSmall particle aerosols of enviroxime-containing liposomesAntiviral Res19889355653228281
  • Gonzalez-RothiRJSchreierHPulmonary delivery of liposome-encapsulated drugs in asthma therapyClin Immunother199543317
  • Gonzales-RothiRJSuarezSHochhausGPulmonary targeting of liposomal triamcinolone acetonide phosphatePharm Res19961316997038956337
  • GreenwayTEEldridgeJHLudwigGInduction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccineVaccine1995161314239682396
  • HiranitaTNakamuraSKawachiMMiscibility behavior of dipalmitoylphosphatidylcholine with a single-chain partially fluorinated amphiphile in Langmuir monolayersJ Colloid and Interface Sci2003265839212927168
  • HungORWhynotSCVarvelJRPharmacokinetics of inhaled liposome-encapsulated fentanylAnesthesiology199583277847631949
  • HyvönenSPeltonenLKarjalainenMEffect of nanoprecipitation on the physicochemical properties of low molecular weight poly(L-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionateInt J Pharm20052952698115848011
  • Illum L. 1997. Polysaccharide microspheres for the pulmonary delivery of drugs: WO 971/35562.
  • JonesMCLerouxJCPolymeric micelles. A new generation of colloidal drug carriersEur J Pharm Biopharm1999481011110469928
  • KanaokaENagataSHiranoKStabilization of aerosolized IFN-gamma by liposomesInt J Pharm19991881657210518672
  • KawashimaYYamamotoHTakeuchiHProperties of a peptide containing DL lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methodsEur J Pharm Biopharm1998454189689534
  • KawashimaYYamamotoHTakeuchiHPulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effectJ Control Rel19996227987
  • KnightVKoshkinaNWaldrepJCAnti-cancer activity of 9-nitrocamptothecin liposome aerosol in miceTransactions of the American Clinicat and Climatological Association20001113545
  • KoshkinaNVKleinermanESWaldrepJC9-nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in miceClin Cancer Res2000628768010914737
  • LangeCFHancockRESamuelJIn vitro aerosol delivery and regional airway surface of liposomal cationic peptideJ Pharm Sci200190164157
  • LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Del20004589121
  • LehrC-MLectin-mediated drug delivery: the second generation of bioadhesivesJ Control Rel2000651929
  • LemarchandCGrefRPassiraniCInfluence of polysaccharide coating on the interactions of nanoparticles with biological systemsBiomaterials2006271081816118015
  • LiFQHuJHLuBCiprofloxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitroJ Microencapsul200118825911695645
  • LiW-IPerzlMHeyderJAerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavitiesJ Aerosol Sci199627126986
  • LiuFYShaoZKildsigDOPulmonary delivery of free and liposomal insulinPharm Res199310228328456069
  • LombryCEdwardsDAPréatVAlveolar macrophages are a primary barrier to pulmonary absorption of macromoleculesAm J Physiol - Lung Cell Mol Physiol2004286L1002814695119
  • MariebENThe respiratory system (chapter 10)Essentials of human anatomy and physiology2005sixth editionBenjamin-Cummings Publishing Company
  • MarshDBartucciRSportelliLLipid membranes with grafted polymers: physicochemical aspectsBiochim Biophys Acta – Biomembranes200316153359
  • MaruyamaKHombergEKennelSJCharacterization of in vivo immunoliposomes targeting to pulmonary endotheliumJ Pharm Sci199079978842292774
  • MorimotoKKatsumataHYabutaTGelatin microspheres as a pulmonary delivery system: evaluation of salmon calcitonin absorptionJ Pharm Pharmacol2000526111710875536
  • MuLFengSSFabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiersJ Control Rel20027623954
  • MüllerRHMaassenSWeyhersHCytotoxicity of magnetite loaded polylactide. polylactide/glycolide particles and solid lipid nanoparticles (SEN)Int J Pharm19961388594
  • MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery - review of the state of the artEur J Pharm Biopharm2000501617710840199
  • MyersMAThomasDAStraubLPulmonary effects of chronic exposure to liposome aerosols in miceExp Lung Res1993191198440200
  • NgKStringerKACohenZAlveolar macrophage cell line is not activated by exposure to polymeric microspheresInt J Pharm1998170419
  • NivenRWSchreierHNebulization of liposomes. I. Effects of lipid compositionPharm Res199071127332293210
  • NivenRWWhitcombLKinstlerOThe pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSFPharm Res199412134398570533
  • NivenRWWhitcombKLWoodwardMSystemic absorption and activity of recombinant consensus interferons after intratracheal instillation and aerosol administrationPharm Res1995121889958786962
  • OmriABeaulacCBouhajibMPulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosaAntimicrob Agents Chemother199438109058067743
  • O’RiordanTGZwangJSmaldoneGCMucociliary clearance in adult asthmaAm Rev Respir Dis19921465986031519834
  • OuyangCChoiceEHollandJLiposomal cyclosporine. Characterization of drug incorporation and interbilayer exchangeTransplantation19956099910067491708
  • PatelNMarlowMLawrenceMJMicroemulsions: a novel pMDI formulation. Drug delivery to the lungs IX1998Bristol, LondonThe Aerosol Society1603
  • PattonJSMechanisms of macromolecular absorption by the lungsAdv Drug Deliv Rev199619336
  • PattonJSBukarJNagarajanSInhaled insulinAdv Drug Deliv Rev1999352354710837699
  • PattonJSFishburnCSWeersJGThe lungs as a portal of entry for systemic drug delivery2004Proceedings of the American Thoracic Society vol 1
  • RajewskiRAStellaVJPharmaceutical applications of cyclodextrins. II. In vivo drug deliveryJ Pharm Sci1996851142698923319
  • SaariSMVidgrenMTKoskinenMORegional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthmaChest1998113157399631796
  • SakagamiMSakonKKinoshitaWEnhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheresJ Control Rel20017711729
  • SayaniAPChienYWSystemic delivery of peptides and proteins across absorptive mucosaeCrit Rev Ther Drug Carrier Sys19961385184
  • SchankerLSDrug absorption from the lungBiochem Pharmacol1978273815629798
  • SchreierHGonzalez-RothiRJStecenkoAAPulmonary delivery of liposomesJ Control Release19932420923
  • ShahiwalaAMisraAPulmonary absorption of liposomal levonorgestrelAAPS PharmSciTech200451E1315198534
  • SommervilleMLCainJBJohnsonCSLecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellantsPharm Dev Tech2000521930
  • SternMUlrichKRobinsonCPretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedemaGene Therapy20007960610849556
  • SuarezSO’HaraPKazantsevaMRespirable PLGA microspheres containin- rifampicin for the C treatment of tuberculosis: screening in an infections disease modelPharm Res20011813151911683246
  • SuntresZEShekPNLiposomes promote pulmonary glucocorticoid deliveryJ Drug Target19986175829888303
  • TakeuchiHYamamotoHKawashimaYMucoadhesive nanoparticulate systems for peptide drug deliveryAdv Drug Del Rev2001473954
  • TaljanskiWPierzynowskiSGLundinPDPulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult ratsDrug Metab Dispos199725917209280398
  • TaylorKMGFarrSJLiposomes for drug delivery to the respiratory tractDrug Dev Industr Pharm19931912342
  • TaylorKMGTaylorGKellawayIWThe stability of liposomes to nebulizationInt J Pharm1990585761
  • TenRMAndersonPMZeinNNInterleukin-2 liposomes for primary immune deficiency using the aerosol routeInt Immunopharmacol200223334411811936
  • TerzanoCAllegraLAlhaiqueFNon phospholipids vesicles for pulmonary glucocorticoid deliveryEur J Pharm Biopharm200559576215567302
  • ThomasDAMyersMAWichertBAcute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteersChest1991991268702019191
  • VermehrenCJørgensenKSchiffelersRActivity of mammalian secreted phospholipase A2 from inflammatory peritoneal fluid towards PEG-liposomes. Early indicationsInt J Pharm200121493811282244
  • VidgrenMWaldrepJCArppeJA study of 99mTechnetium-labeled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteersInt J Pharm199411520916
  • WaldrepJCArppeJJansaKAHigh dose cyclosporin A and budesonide-liposome aerosolsInt J Pharm19971522736
  • WaldrepJCGilbertBEKnightCMPulmonary delivery of beclomethasone liposome aerosol in volunteersChest1997111316239041975
  • WaldrepJCNieminenMSaariMPulmonary deposition and clearance of 99mTC-labeled beclomethasone liposomes in mild and severe asthmaticsRespir Crit Care Med1997155 abstract
  • WangDRobinsonDRKwonGSEncapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolyc acid) microspheres as a novel approach for immunogene deliveryJ Control Release1999579189863034
  • WashingtonNWashingtonCWilsonCPulmonary Drug delivery (chapter ten)Physiological pharmaceutics – barriers to drug absorption2001Second editionNew YorkTaylor and Francis
  • WilliamsROIIIBarronMKAlonsoMJInvestigation of a pMDI system coniaining chitosan microspheres and Pl34aInt J Pharm200017420922
  • YamamotoATanakaHOkumuraSEvaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using xenopus pulmonary membraneBiol Pharm Bull200124385911305600
  • ZengXMMartinGPMarriottCPreparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drag delivery systemEur J Pharm Sci199538793
  • ZhangQShenZNagaiTProlonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal ratsInt J Pharm2001218758011337151